X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Data Release: Whole Human Transcriptome from Brain, Heart, and Liver

Tuesday, October 21, 2014

In higher eukaryotic organisms, like humans, RNA transcripts from the vast majority of genes are alternatively spliced. Alternative splicing dramatically increases the protein-coding potential of eukaryotic genomes and its regulation is often specific to a given tissue or developmental stage.

Using our updated Iso-Seq™ sample preparation protocol, we have generated a dataset containing the full-length whole transcriptome from three diverse human tissues (brain, heart, and liver). The updated version of the Iso-Seq method incorporates the use of a new PCR polymerase that improves the representation of larger transcripts, enabling sequencing of cDNAs of nearly 10 kb in length. The inclusion of multiple sample types makes this dataset ideal for exploring differential alternative splicing events. Download the polished, full-length transcript sequences and the raw data files.

We have also uploaded the polished, full-length, non-redundant transcript set onto the UCSC Genome Browser to enable browsing of the data. An example of the data is shown below in Figure 2. Access the genome browser tracks.

Materials and Methods

Human mRNA samples were purchased from Biochain. Amplified double-stranded cDNA was generated as outlined in the updated version of the Iso-Seq target preparation protocol. The distribution of cDNA sizes was determined by running the amplified cDNA on a Bioanalyzer (Figure 1). The amplified cDNA was size fractionated on a BluePippin™ system (Sage Science). Size fractions of 1-2 kb, 2-3 kb, 3-6 kb, and 5-10 kb were collected, purified, and subjected to an additional round of PCR amplification. The 5-10 kb fraction was not collected for the liver sample because there were insufficient transcripts of ≥ 5 kb (Figure 1).

SMRTbell™ libraries were generated from each size fraction and sequenced independently. SMRTbell templates from the 3-6 kb and 5-10 kb fractions were cleaned up using the BluePippin system. The libraries were sequenced with a combination of P4-C2 and P5-C3 sequencing chemistries on a PacBio RS II with 2- or 3-hour movies. After sequencing, the data was processed using the “RS_IsoSeq.1” analysis pipeline with SMRT® Portal version 2.2. A summary of the sequencing results is shown in Table 1.

Table 1:  Summary of Sequencing Results
General sequencing statistics for each sample/size bin combination are shown along with statistics for each tissue.

Figure 1:  Size Distribution of Amplified cDNA
Approximately 50 ng of amplified cDNA from each tissue was run on an Agilent Bioanalzyer DNA 7500 kit. The plot shows the electropherogram with each tissue color coded.

Figure 2:  UCSC Genome Browser Screen Shot
Example data for the DCTN1 gene as shown in the UCSC Genome Browser. Polished, non-redundant, full-length transcript sequences are shown for each tissue.

Subscribe for blog updates:

Archives